Mitteilungsseiten des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK)

• Literatur

• 1 Stop TB Partnership. The potential impact of the COVID-19 response on tuberculosis in high-burden countries: a modelling analysis. 2020 Im Internet (Stand 27.12.2020): http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf
• 2 Glaziou P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv 2020;
• 3 McQuaid CF, McCreesh N, Read JM. et al. The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J 2020; 56: 156
• 4 WHO. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020
• 5 Stop TB Partnership. The potential impact of Covid-19 on global resource needs for TB and its impact on the TB Global Plan 2018–2022. 2020
• 6 Cilloni L, Fu H, Vesga JF. et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine 2020; 28: 100603
• 7 Otto-Knapp R, Häcker B, Breuer C. et al. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany – (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)]. Pneumologie 2020; 74: 412-158
• 8 Lommatzsch M, Rabe KF, Taube C. et al. [Risk Assessment for Patients with Chronic Respiratory and Pulmonary Conditions in the Context of the SARS-CoV-2 Pandemic - Statement of the German Respiratory Society (DGP) with the Support of the German Association of Respiratory Physicians (BdP)]. Pneumologie 2021; 75: 19-30
• 9 Vernon A, Fielding K, Savic R. et al. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med 2019; 16: e1002884
• 10 Imperial MZ, Nahid P, Phillips PPJ. et al. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nat Med 2018; 24: 1708-1715
• 11 Häcker B, Kaufmann SHE, Bauer T. et al. History of BCG Vaccination Recommendations in East and West Germany from 1951 to Date. Pneumologie 2020; 74: 811-812
• 12 WHO. Consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020 Licence: CC BY-NC-SA 3.0 IGO
• 13 WHO. Consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection. Geneva: World Health Organization; 2020 Licence: CC BY-NC-SA 3.0 IGO
• 14 WHO. Consolidated guidelines on tuberculosis. Module 4: treatment – drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020 Licence: CC BY-NC-SA 3.0 IGO
• 15 Schaberg T, Bauer T, Brinkmann F. et al. S2k-Leitlinie: Tuberkulose im Erwachsenenalter – Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 2017; 71: 325-397
• 16 Otto-Knapp R, Knappik M, Häcker B. et al. [The New WHO Guidelines for Rapid Diagnostics and Treatment of Drug-Resistant Tuberculosis Commented for Germany, Austria and Switzerland]. Pneumologie 2020; 74: 742-749
• 17 Gupta RK, Calderwood CJ, Yavlinsky A. et al. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med 2020; 26: 1941-1949